Analytical Data
-
基因名
ZIK1
- Application
-
别名
ZIK1; ZNF762Zinc finger Protein interacting with ribonucleoProtein K; Zinc finger Protein 762
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q3SY52
-
表达区间
1-384 aa
-
氨基酸序列
MCVPVLKDILHLADLPGQKPYLVGECTNHHQHQKHHSAKKSLKRDMDRASYVKCCLFCMSLKPFRKWEVGKDLPAMLRLLRSLVFPGGKKPGTITECGEDIRSQKSHYKSGECGKASRHKHTPVYHPRVYTGKKLYECSKCGKAFRGKYSLVQHQRVHTGERPWECNECGKFFSQTSHLNDHRRIHTGERPYECSECGKLFRQNSSLVDHQKIHTGARPYECSQCGKSFSQKATLVKHQRVHTGERPYKCGECGNSFSQSAILNQHRRIHTGAKPYECGQCGKSFSQKATLIKHQRVHTGERPYKCGDCGKSFSQSSILIQHRRIHTGARPYECGQCGKSFSQKSGLIQHQVVHTGERPYECNKCGNSFSQCSSLIHHQKCHNT
-
分子量
70.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZIK1 recombinant protein has garnered significant attention in recent years due to its potential implications in understanding and combating Zika virus infections, which have emerged as a global public health concern. Zika virus, primarily transmitted by Aedes mosquitoes, is linked to severe neurological complications, including microcephaly in newborns and Guillain-Barré syndrome in adults. The development of ZIK1 recombinant protein is pivotal for various research applications, including vaccine development, diagnostic assays, and therapeutic interventions. By expressing and purifying ZIK1, researchers can explore its structural and functional properties, facilitating the design of targeted strategies to inhibit viral entry and replication. Furthermore, studying ZIK1 in the context of immune responses aids in identifying potential immunogenic epitopes, which are critical for informing vaccine design. Given the lack of specific antiviral treatments for Zika virus and increasing incidences worldwide, the establishment of robust research tools, such as ZIK1 recombinant protein, is essential for advancing our understanding of the virus and developing effective countermeasures against future outbreaks.
